Apiam Animal Health Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Apiam Animal Health.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth	23.7%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

Recent updates

There's Reason For Concern Over Apiam Animal Health Limited's (ASX:AHX) Price

Aug 08

Subdued Growth No Barrier To Apiam Animal Health Limited (ASX:AHX) With Shares Advancing 30%

Feb 24

These 4 Measures Indicate That Apiam Animal Health (ASX:AHX) Is Using Debt Extensively

Oct 12

Apiam Animal Health (ASX:AHX) Has Announced That Its Dividend Will Be Reduced To A$0.004

Sep 02

Apiam Animal Health (ASX:AHX) Has Re-Affirmed Its Dividend Of AU$0.012

Feb 28

Here's Why We Think Apiam Animal Health Limited's (ASX:AHX) CEO Compensation Looks Fair for the time being

Nov 18

Apiam Animal Health Limited's (ASX:AHX) Intrinsic Value Is Potentially 43% Above Its Share Price

Mar 12

Should You Or Shouldn't You: A Dividend Analysis on Apiam Animal Health Limited (ASX:AHX)

Feb 25

How Is Apiam Animal Health's (ASX:AHX) CEO Compensated?

Feb 08

Should Weakness in Apiam Animal Health Limited's (ASX:AHX) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Jan 18

Does Apiam Animal Health (ASX:AHX) Have A Healthy Balance Sheet?

Dec 28

Apiam Animal Health Limited's (ASX:AHX) Intrinsic Value Is Potentially 91% Above Its Share Price

Dec 11

Is Apiam Animal Health Limited (ASX:AHX) The Right Choice For A Smart Dividend Investor?

Nov 24

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Apiam Animal Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

ASX:AHX - Analysts future estimates and past financials data (AUD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
6/30/2024	205	5	14	19	N/A
3/31/2024	204	4	12	19	N/A
12/31/2023	202	3	11	18	N/A
9/30/2023	197	2	10	18	N/A
6/30/2023	192	2	9	17	N/A
3/31/2023	184	4	10	17	N/A
12/31/2022	176	6	12	17	N/A
9/30/2022	166	5	11	16	N/A
6/30/2022	157	5	11	15	N/A
3/31/2022	149	4	9	14	N/A
12/31/2021	140	4	8	13	N/A
9/30/2021	133	5	9	13	N/A
6/30/2021	126	5	9	14	N/A
3/31/2021	125	5	8	12	N/A
12/31/2020	123	5	8	11	N/A
9/30/2020	121	5	7	9	N/A
6/30/2020	118	4	6	8	N/A
3/31/2020	115	4	4	7	N/A
12/31/2019	112	3	3	6	N/A
9/30/2019	112	3	3	5	N/A
6/30/2019	112	3	2	5	N/A
3/31/2019	112	3	2	6	N/A
12/31/2018	112	3	3	7	N/A
9/30/2018	109	3	4	8	N/A
6/30/2018	107	3	4	9	N/A
3/31/2018	105	3	N/A	7	N/A
12/31/2017	103	4	N/A	5	N/A
9/30/2017	100	4	N/A	4	N/A
6/30/2017	98	5	N/A	2	N/A
3/31/2017	94	5	N/A	0	N/A
12/31/2016	90	5	N/A	-2	N/A
9/30/2016	72	3	N/A	-1	N/A
6/30/2016	54	0	N/A	-1	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if AHX's forecast earnings growth is above the savings rate (2.6%).

Earnings vs Market: Insufficient data to determine if AHX's earnings are forecast to grow faster than the Australian market

High Growth Earnings: Insufficient data to determine if AHX's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if AHX's revenue is forecast to grow faster than the Australian market.

High Growth Revenue: Insufficient data to determine if AHX's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if AHX's Return on Equity is forecast to be high in 3 years time

Discover growth companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/02 07:27
End of Day Share Price	2025/01/02 00:00
Earnings	2024/06/30
Annual Earnings	2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Apiam Animal Health Limited is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Russell Wright	Barclay Pearce Capital Pty Limited
Louis Bannon	CCZ Equities Pty Limited
Jonathon Higgins	Shaw and Partners Limited

Apiam Animal Health Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Consensus EPS estimates fall by 17%

Price target decreased by 8.0% to AU$0.86

Price target increased to AU$1.13

Consensus forecasts updated

Consensus forecasts updated

Price target increased to AU$0.85

Recent updates

Apiam Animal Health Limited, Annual General Meeting, Nov 21, 2024

An undisclosed buyer terminated the acquisition of Apiam Animal Health Limited (ASX:AHX)

Apiam Animal Health Limited Announces Board Changes

Full year 2024 earnings released: EPS: AU$0.028 (vs AU$0.013 in FY 2023)

Apiam Animal Health Limited to Report Fiscal Year 2024 Results on Aug 23, 2024

There's Reason For Concern Over Apiam Animal Health Limited's (ASX:AHX) Price

MD & Executive Director recently bought AU$596k worth of stock

Upcoming dividend of AU$0.01 per share

Subdued Growth No Barrier To Apiam Animal Health Limited (ASX:AHX) With Shares Advancing 30%

Apiam Animal Health Limited to Report First Half, 2024 Results on Feb 23, 2024

Apiam Animal Health Limited, Annual General Meeting, Nov 23, 2023

These 4 Measures Indicate That Apiam Animal Health (ASX:AHX) Is Using Debt Extensively

MD & Executive Director recently bought AU$134k worth of stock

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

New minor risk - Financial data availability

Apiam Animal Health Limited to Report Fiscal Year 2023 Results on Aug 28, 2023

Consensus EPS estimates fall by 17%

Price target decreased by 8.0% to AU$0.86

First half 2023 earnings released: EPS: AU$0.017 (vs AU$0.013 in 1H 2022)

Apiam Animal Health Limited to Report First Half, 2023 Results on Feb 24, 2023

Apiam Animal Health Limited (ASX:AHX) acquired Hunter Equine Centre Pty Ltd for AUD 6.5 million.

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire Harradine and Associates for AUD 2.6 million.

Apiam Animal Health Limited, Annual General Meeting, Nov 24, 2022

MD & Executive Director recently sold AU$354k worth of stock

Price target increased to AU$1.13

Apiam Animal Health (ASX:AHX) Has Announced That Its Dividend Will Be Reduced To A$0.004

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Apiam Animal Health Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended June 30, 2022, Payable on October 21, 2022

Apiam Animal Health Limited to Report Fiscal Year 2022 Results on Aug 29, 2022

Consensus forecasts updated

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire assets of Victorian Equine Group and Romsey Veterinary Surgery for AUD 13.75 million.

Insufficient new directors

Upcoming dividend of AU$0.012 per share

Consensus forecasts updated

First half 2022 earnings: EPS misses analyst expectations

Apiam Animal Health (ASX:AHX) Has Re-Affirmed Its Dividend Of AU$0.012

Apiam Animal Health Limited Announces Ordinary Fully Franked Dividend for the Period Ended December 31, 2021, Payable on April 20, 2022

Apiam Animal Health Limited to Report First Half, 2022 Results on Feb 25, 2022

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire Fraser Coast Veterinary Services.

Here's Why We Think Apiam Animal Health Limited's (ASX:AHX) CEO Compensation Looks Fair for the time being

MD & Executive Director recently bought AU$96k worth of stock

Apiam Animal Health (ASX:AHX) Has Announced A Dividend Of AU$0.012

Apiam Animal Health Limited (ASX:AHX) completed the acquisition of Harbour City Veterinary Surgery.

Insufficient new directors

Apiam Animal Health (ASX:AHX) Has Re-Affirmed Its Dividend Of AU$0.012

Full year 2021 earnings released: EPS AU$0.042 (vs AU$0.037 in FY 2020)

Price target increased to AU$0.85

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire Harbour City Veterinary Surgery for AUD 2.8 million.

Apiam Animal Health Limited (ASX: AHX) acquired Assets of Golden Plains Animal Hospital.

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire The Scenic Rim for AUD 16 million.

A Look At The Fair Value Of Apiam Animal Health Limited (ASX:AHX)

Apiam Animal Health Limited (ASX:AHX) completed the acquisition of Samford Valley Veterinary Hospital.

Apiam Animal Health Limited (ASX:AHX) acquired Clermont Veterinary Surgery.

MD & Executive Director recently bought AU$252k worth of stock

With EPS Growth And More, Apiam Animal Health (ASX:AHX) Is Interesting

Only Four Days Left To Cash In On Apiam Animal Health's (ASX:AHX) Dividend

Apiam Animal Health Limited's (ASX:AHX) Intrinsic Value Is Potentially 43% Above Its Share Price

Upcoming Dividend of AU$0.012 Per Share

New 90-day high: AU$0.74

Analysts update estimates

Should You Or Shouldn't You: A Dividend Analysis on Apiam Animal Health Limited (ASX:AHX)

First half 2021 earnings released: EPS AU$0.022 (vs AU$0.015 in 1H 2020)

Apiam Animal Health Limited to Report First Half, 2021 Results on Feb 24, 2021

How Is Apiam Animal Health's (ASX:AHX) CEO Compensated?

Should Weakness in Apiam Animal Health Limited's (ASX:AHX) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

New 90-day low: AU$0.57

Does Apiam Animal Health (ASX:AHX) Have A Healthy Balance Sheet?

New 90-day low: AU$0.60

Price target lowered to AU$0.59